"GeoArea_Code","GeoArea_Desc","GoalCode","GoalDesc","TargetCode","TargetDesc","IndicatorCode","IndicatorDesc","IndicatorTier","SeriesCode","SeriesDesc","SeriesRelease","Units_Code","Units_Desc","ReportingType_Code","ReportingType_Desc","Unitmultiplier_Code","Unitmultiplier_Desc","Value_2000.0","Value_2001.0","Value_2002.0","Value_2003.0","Value_2004.0","Value_2005.0","Value_2006.0","Value_2007.0","Value_2008.0","Value_2009.0","Value_2010.0","Value_2011.0","Value_2012.0","Value_2013.0","Value_2014.0","Value_2015.0","Value_2016.0","Latest_Year","Latest_Value","Nature_Desc","Source","Footnotes"
"1","World","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","2146.44","1925.67","2104.92","2183.69","2602.77","3818.29","4317.52","5229.28","5201.47","6025.52","6644.68","6316.61","7109.19","8680.12","7897.15","9343.11","9359.19",2016.0,"9359.19","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)",""
"2","Africa","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","730.17936","891.95061","688.97549","780.11932","963.50627","1184.77749","1503.81064","1751.20553","2192.95375","2647.75668","2791.89255","3011.40929","3595.69343","4445.53041","4141.34769","5040.63607","4818.10372",2016.0,"4818.10372","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"5","South America","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","80.10028","60.92524","43.57436","64.2528","67.14381","111.51119","111.75726","118.60057","137.06047","134.45523","142.52273","108.1364","93.17473","86.61131","49.9975","50.91513","60.50113",2016.0,"60.50113","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"9","Oceania","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","125.29713","9.60003","77.4239","67.11089","51.27809","59.34243","32.29122","40.22995","59.86185","78.92972","48.75416","70.05104","66.52032","85.96266","44.78368","118.01139","59.34631",2016.0,"59.34631","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"11","Western Africa","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","133.92367","246.44938","159.20462","201.23863","307.32777","320.44862","446.73129","475.43954","663.3656","996.32064","896.83343","820.61153","1028.93414","1262.891","1420.14925","1897.98761","1628.54788",2016.0,"1628.54788","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"13","Central America","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","37.33351","47.19276","43.32557","49.11462","46.17207","78.82899","87.11062","98.48074","97.15998","83.32791","80.74626","76.09845","82.44297","73.12572","79.93943","113.29755","81.42944",2016.0,"81.42944","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"14","Eastern Africa","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","403.95312","406.27912","338.25175","413.6585","447.49187","549.44194","739.62457","868.6824","950.88664","1116.39848","1264.41355","1463.04672","1830.98934","2261.48279","1946.89984","2190.1802","2191.89779",2016.0,"2191.89779","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"15","Northern Africa","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","61.93589","49.99872","61.98964","35.61639","55.87963","113.21392","100.46986","154.17614","174.3788","111.49428","161.23526","120.62078","130.09078","135.86136","105.84549","130.71237","222.31343",2016.0,"222.31343","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"17","Middle Africa","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","112.4803","119.44542","93.00925","95.08167","128.46918","172.54908","169.18476","206.74252","363.69727","362.36069","421.46661","486.73097","515.27601","622.40135","619.21603","718.69558","641.09153",2016.0,"641.09153","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"18","Southern Africa","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","17.88637","69.77797","36.52023","34.52414","24.33782","29.12394","47.80016","46.16494","40.62544","61.18259","47.9437","120.39929","90.40316","162.89391","49.23707","103.06031","134.25309",2016.0,"134.25309","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"19","Americas","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"21","Northern America","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"29","Caribbean","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","22.76249","16.91908","13.81972","19.46932","19.24489","23.44988","35.99995","26.84634","40.61897","24.5015","31.39894","83.4913","64.94162","69.0629","52.15928","64.05408","99.85787",2016.0,"99.85787","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"30","Eastern Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","51.50941","35.74485","49.72607","61.65522","58.92858","57.22548","57.48718","113.71733","67.7343","124.17678","152.95907","105.52573","143.63329","123.69736","102.77176","108.02582","202.85375",2016.0,"202.85375","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"34","Southern Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","471.54102","269.22868","392.2216","328.27403","377.50088","586.33401","698.86037","751.18722","746.47407","787.91954","1001.28168","779.44967","882.12128","1232.40853","918.16761","1120.47805","1189.08239",2016.0,"1189.08239","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"35","South-Eastern Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","192.4071","135.54243","112.37428","144.69938","129.55288","214.9705","298.46514","315.79483","341.23354","372.85663","504.37074","408.76305","534.41067","551.85528","495.0022","507.79648","546.65281",2016.0,"546.65281","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"39","Southern Europe","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","32.76981","29.46014","17.02746","23.80636","15.20107","28.60582","38.60972","30.69002","22.83714","8.13554","15.95891","15.18564","10.94003","10.75745","15.20779","9.62384","39.92902",2016.0,"39.92902","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"53","Australia and New Zealand","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"54","Melanesia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","125.20597","3.68466","72.13691","55.358","48.9804","42.53288","26.01462","35.15445","56.73628","75.5205","41.3009","56.10506","57.76404","75.85209","41.63844","101.10232","47.50039",2016.0,"47.50039","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"57","Micronesia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","0.09022","","0.11121","8.05527","1.00046","3.38415","2.28321","1.6446","1.20713","2.3787","0.82925","0.83206","2.28603","2.3303","1.45561","9.37532","2.11174",2016.0,"2.11174","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"61","Polynesia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","0.00093","5.91537","5.17578","3.69762","1.29723","13.4254","3.9934","3.4309","1.91844","1.03052","6.62402","13.11393","6.47025","7.78027","1.68963","7.53375","9.73418",2016.0,"9.73418","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"62","Central and Southern Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"97","European Union","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"127","Southern Asia (excluding India)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","148.70144","143.73215","109.27198","127.31855","186.62339","305.0292","445.22175","510.19615","541.83059","605.42423","737.42462","487.81467","635.57133","869.92932","683.80897","731.24366","817.43061",2016.0,"817.43061","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"135","Caucasus and Central Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","40.74651","36.19827","50.17453","46.91113","57.81799","57.555","65.00777","85.0659","89.43823","98.82494","130.20898","124.44762","112.5919","103.6371","116.57781","89.88125","144.22976",2016.0,"144.22976","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"142","Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","830.27588","506.30808","645.96452","661.89573","770.59763","1531.67721","1635.81502","1614.33377","1447.5356","1602.48276","2014.14537","1584.77426","1860.93775","2214.89378","1889.17683","2078.73088","2335.24399",2016.0,"2335.24399","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"143","Central Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","20.51836","25.92225","39.46087","39.4174","52.02842","41.92624","46.63555","48.1468","60.6654","68.48632","90.01193","84.34879","93.6722","75.78936","96.2838","75.18252","116.94816",2016.0,"116.94816","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"145","Western Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","94.29999","39.86986","52.1817","87.8497","152.58687","631.22098","534.36677","385.4876","231.4283","249.04349","265.52195","206.68702","207.10031","231.14326","276.95146","267.24801","279.70689",2016.0,"279.70689","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"150","Europe","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","42.73768","30.75048","18.2995","24.82466","16.98014","40.55577","57.13034","50.79156","50.51077","35.08581","46.80962","62.09594","61.49515","59.96793","63.28701","73.23727","124.76854",2016.0,"124.76854","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"151","Eastern Europe","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","9.96786","1.29034","1.27204","1.0183","1.77908","11.94996","18.52062","20.10155","27.67364","26.95027","30.85071","46.9103","50.55512","49.21048","48.07922","63.61343","84.83952",2016.0,"84.83952","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"154","Northern Europe","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"155","Western Europe","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"158","Other non-specified areas","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"199","Least Developed Countries (LDCs)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","779.98467","724.81023","610.6169","738.76735","910.15244","1252.81898","1521.54539","1708.4013","2154.13846","2279.7392","2657.63795","2738.77382","3264.42338","4193.00189","4007.49889","4445.82707","4415.25251",2016.0,"4415.25251","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"202","Sub-Saharan Africa","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","668.24347","841.95189","626.98585","744.50293","907.62664","1071.56357","1403.34078","1597.02939","2018.57495","2536.26241","2630.65729","2890.78851","3465.60265","4309.66905","4035.5022","4909.9237","4595.79029",2016.0,"4595.79029","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"223","Eastern Asia (excluding Japan and China)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","13.00774","1.98835","3.99286","2.58429","3.64611","6.33362","2.11416","13.14899","9.63353","20.4586","36.23535","33.1867","28.3853","32.53706","31.56644","28.46381","42.47734",2016.0,"42.47734","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"369"," Iraq (Central Iraq) ","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"419","Latin America and the Caribbean","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","140.19628","125.03708","100.71965","132.83674","132.56076","213.79006","234.86784","243.92765","274.83943","242.28464","254.66794","267.72614","240.55932","228.79993","182.0962","228.26676","241.78843",2016.0,"241.78843","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"420","Latin America","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"432","Landlocked developing countries (LLDCs)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","410.24752","421.63676","324.24527","464.81811","519.20377","674.78516","859.88565","1072.29849","1088.87305","1252.16716","1323.55992","1529.48647","1804.19145","2242.0536","1939.94177","2054.05982","2369.15725",2016.0,"2369.15725","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"485","Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"513","Europe and Northern America","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","42.73768","30.75048","18.2995","24.82466","16.98014","40.55577","57.13034","50.79156","50.51077","35.08581","46.80962","62.09594","61.49515","59.96793","63.28701","73.23727","124.76854",2016.0,"124.76854","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"515","Developing regions","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"518","Eastern Asia (excluding Japan)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"535","Bonaire, Sint Eustatius and Saba","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"543","Oceania (exc. Australia and New Zealand)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"722","Small island developing States (SIDS)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","155.01304","48.54606","98.14253","94.87542","88.95371","103.09463","93.94863","87.56837","124.64126","130.45011","130.93082","180.41984","181.84144","215.4754","132.88903","230.87812","214.31147",2016.0,"214.31147","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)","[2000-2001]: Commitments; Based on OECD, CRS databased, 2018; Constant 2016 USD million // [2002-2016]: Gross disbursements; Based on OECD, CRS databased, 2018; Constant 2016 USD million"
"738","Sub-Saharan Africa (inc. Sudan)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"746","Northern Africa (exc. Sudan)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"747","Northern Africa and Western Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"753","Eastern and South-Eastern Asia","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"827","United Kingdom (England and Wales)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"828","United Kingdom (Northern Ireland)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"829","United Kingdom (Scotland)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"830","Channel Islands","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"891","Serbia and Montenegro [former]","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"910","High income economies (WB)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"911","Low income economies (WB)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"912","Lower middle economies (WB)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"913","Low and middle income economies (WB)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"914","Upper middle economies (WB)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"917","International Centers (FAO)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"918","European Union (EU) Institutions","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"919","Regional Centres (FAO)","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"920","Azores Islands","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","","","","","","","","","","","","","","","","","","","","","",""
"921","ODA residual","3","Ensure healthy lives and promote well-being for all at all ages","3.b","Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","3.b.2","Total net official development assistance to medical research and basic health sectors","1","DC_TOF_HLTHL","Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)","2019.Q1.G.01","CON_USD","Constant USD","G","Global","UNIT","Units","277.75","362.03","573.54","516.90","667.85","788.15","853.60","1528.79","1175.77","1418.98","1488.41","1320.56","1283.98","1644.96","1576.46","1804.23","1779.94",2016.0,"1779.94","Data nature not available","Creditor Reporting System (CRS) database, 2018, The Organisation for Economic Co-operation and Development (OECD)",""
